S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2-Reference-Cited by-同舟云学术

S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2

Published:2022-05-04 Issue:9 Volume:65 Page:6496-6498
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tyndall Joel D. A.¹^ORCID

Affiliation:

1. School of Pharmacy, University of Otago, Dunedin 9054, New Zealand

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00624

Reference12 articles.

1. WHO. 10 Vaccines Granted Emergency Use Listing (EUL) by WHO, 2022. https://covid19.trackvaccines.org/agency/who/ (accessed Apr 20, 2022).

2. U.S. Food & Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19. Dec 22, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19.

3. Proteases and protease inhibitors in infectious diseases

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease;Biomolecules;2024-06-25

2. Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review;Bioorganic Chemistry;2024-06

3. Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network;Journal of Chemical Information and Modeling;2024-03-23

4. Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups;Bioorganic Chemistry;2024-02

5. D3Rings: A Fast and Accurate Method for Ring System Identification and Deep Generation of Drug-Like Cyclic Compounds;Journal of Chemical Information and Modeling;2024-01-11